Viewing Study NCT03245528


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-06-17 @ 7:36 PM
Study NCT ID: NCT03245528
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2018-03-08
First Post: 2017-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access for LJPC-501
Sponsor: La Jolla Pharmaceutical Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Catecholamine Resistant Hypotension (CRH) View
None Distributive Shock View
None High Output Shock View
None Sepsis View
None Vasodilatory Shock View
Keywords: